Canada Pulls Controversial Pricing Measures
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
You may also be interested in...
New draft guidelines outlining how Canada’s drug pricing authority will decide whether to investigate if a medicine is excessively priced are now out for consultation.
Provisional guidance on controversial pricing reforms is now in place in Canada.
Changes to Canada’s reference pricing system kick in on 1 July and could save billions.